BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Selby NM, Fonseca SA, Fluck RJ, Taal MW. Hemoglobin variability with epoetin beta and continuous erythropoietin receptor activator in patients on peritoneal dialysis. Perit Dial Int 2012;32:177-82. [PMID: 22045101 DOI: 10.3747/pdi.2010.00299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Arikan H, Asicioglu E, Velioglu A, Nalcaci S, Birdal G, Guler D, Koc M, Tuglular S, Ozener C. Determinants of hemoglobin variability in stable peritoneal dialysis patients. Int Urol Nephrol 2014;46:1427-34. [PMID: 24687636 DOI: 10.1007/s11255-014-0700-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Ohashi N, Sakao Y, Yasuda H, Kato A, Fujigaki Y. Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease. Int J Nephrol Renovasc Dis 2012;5:53-60. [PMID: 22536082 DOI: 10.2147/IJNRD.S23447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Trivedi H, Yang J, Szabo A. Gastrointestinal bleeding in patients on long-term dialysis. J Nephrol 2015;28:235-43. [PMID: 25185727 DOI: 10.1007/s40620-014-0132-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
4 Washida N, Inoue S, Kasai T, Shinozuka K, Hosoya K, Morimoto K, Wakino S, Hayashi K, Itoh H. Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients: Switching from Darbepoietin Alfa to Epoetin Beta Pegol. Ther Apher Dial 2015;19:450-6. [DOI: 10.1111/1744-9987.12306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
5 Pirkle JL Jr, Paoli CJ, Russell G, Petersen J, Burkart J. Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment system. Clin Ther 2014;36:1665-74. [PMID: 25256386 DOI: 10.1016/j.clinthera.2014.08.011] [Reference Citation Analysis]
6 Koch M, Treiber W, Fliser D. Effective achievement of hemoglobin stability with once-monthly C.E.R.A. in peritoneal dialysis patients: a prospective study. Clin Drug Investig 2013;33:699-706. [PMID: 23975657 DOI: 10.1007/s40261-013-0091-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zeidan A, Bhandari S. Anemia in Peritoneal Dialysis Patients; Iron Repletion, Current and Future Therapies. Perit Dial Int 2017;37:6-13. [PMID: 28153964 DOI: 10.3747/pdi.2016.00193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
8 González MT, Ramos R, Vera M, Barbosa F, Garcia C, Garcia I, González-Segura C, Cuxart M, Teixidó J, José de la Cruz J. Monthly CERA treatment maintains stable hemoglobin levels in routine clinical practice of peritoneal dialysis patients. Ren Fail 2013;35:314-9. [PMID: 23356501 DOI: 10.3109/0886022X.2012.755903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
9 Bakkaloğlu SA, Kandur Y, Serdaroğlu E, Noyan A, Bayazıt AK, Taşdemir M, Özlü SG, Özçelik G, Dursun İ, Alparslan C, Akcaboy M, Atikel YÖ, Parmaksız G, Atmış B, Sever L. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients. Pediatr Nephrol 2018;33:2143-50. [PMID: 30105415 DOI: 10.1007/s00467-018-4013-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gupta AK, David W. Does erythropoietin cause hemoglobin variability--is it 'normal'? PLoS One 2014;9:e92890. [PMID: 24709756 DOI: 10.1371/journal.pone.0092890] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB. Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study. Clin Nephrol 2017;88:254-65. [PMID: 28899480 DOI: 10.5414/CN109031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Perlman RL, Zhao J, Fuller DS, Bieber B, Li Y, Pisoni RL, Robinson BM, Johnson DW, Kawanishi H, Davies SJ, Schreiber MJ, Perl J. International Anemia Prevalence and Management in Peritoneal Dialysis Patients. Perit Dial Int 2019;39:539-46. [PMID: 31582465 DOI: 10.3747/pdi.2018.00249] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 Schmid H. Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure. Expert Rev Hematol 2016;9:5-20. [PMID: 26573694 DOI: 10.1586/17474086.2016.1112734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]